Michael Dixon is President and CEO, working with faculty, students and staff to help commercialize innovative, new ideas that have the potential to improve public health in Nebraska and beyond. Dr. Dixon is responsible for setting UNeMed’s strategic path while directing efforts to protect, market and license new technologies.
Dr. Dixon is a graduate of Leadership Omaha Class 32 and a 2011 recipient of the Midlands Business Journal “40 under 40” award. As an active member of the community, Dr. Dixon serves on several Boards of Directors, including Invest Nebraska Corporation, a non-profit, venture development organization that advises and invests in companies and early stage business ideas in Nebraska. He also sits on the board of Bio Nebraska, a nonprofit trade association dedicated to the development and growth of Nebraska’s bioscience industry.
Dr. Dixon holds a doctorate in Pathology and Microbiology from UNMC.
Sign up to view 7 direct reports
Get started